MedPath

EPTIFIBATIDE INJECTION

EPTIFIBATIDE INJECTION

Discontinued
DIN Number

02367858

Drug Class

Human

Market Date

Apr 29, 2013

Company
HC

teva canada limited

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02367858
AIG Number0137621002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
B01AC16 EPTIFIBATIDE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification20:12.18
Health Canada Classification

ACTIVE INGREDIENTS (1)

EPTIFIBATIDEActive
Strength: 2 MG / ML
Monograph: EPTIFIBATIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.